Linder Adam A - OmicsDI

Previous page
1 / 2
You're on page 1
page 2
Next page

Sort by:

Relevance

Page size

Structural and Functional Analyses of the Shedding Protease ADAM17 in HoxB8-Immortalized Macrophages and Dendritic-like Cells.

Not available

S-EPMC6215251 | biostudies-literature

Population scale proteomics enables adaptive digital twin modelling in sepsis

1364 plasma proteome samples taken at time-of-admission to the emergency department from patients suspected of sepsis. Used initially with the following abstract: Sepsis is one of the leading causes of mortality in the world. Currently, the heterogeneity of sepsis makes it challenging to determine...

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

2024-04-08 | MSV000094486 | MassIVE

Transcatheter aortic valve implantation in patients with a small aortic annulus: performance of supra-, intra- and infra-annular transcatheter heart valves.

Not available

S-EPMC8639544 | biostudies-literature

An Endotoxin Tolerance Signature Predicts Sepsis and Organ Dysfunction at Initial Clinical Presentation

Background: Sepsis involves aberrant immune responses to infection, but the exact nature of this immune dysfunction remains poorly defined. Bacterial endotoxins like lipopolysaccharide (LPS) are potent inducers of inflammation, which has been associated with the pathophysiology of sepsis, but repeat...

ORGANISM(S): Homo sapiens

2014-11-14 | E-GEOD-63311 | biostudies-arrayexpress

Global anaesthesia practice using inguinal hernia surgery as a tracer condition: a secondary analysis of an international prospective cohort study.

Not available

S-EPMC12519944 | biostudies-literature

A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts.

Not available

S-EPMC12056793 | biostudies-literature

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.

Not available

S-EPMC7894131 | biostudies-literature

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.